As per NAVADHI Market Research, the global
pharmaceutical industry will we worth USD 1.57 trillion by 2023.
Johnson & Johnson and its subsidiaries (the
Company) have approximately 134,000 employees worldwide engaged in the research
and development, manufacture and sale of a broad range of products in the
health care field. Johnson & Johnson is a holding company, which has more
than 260 operating companies conducting business in virtually all countries of
the world. The Company’s primary focus is products related to human health and
well-being. Johnson & Johnson was incorporated in the State of New Jersey
in 1887.
The Company is organized into three business
segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment
includes a broad range of products used in the baby care, oral care, beauty,
over-the-counter pharmaceutical, women’s health and wound care markets. The
Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g.,
rheumatoid arthritis, inflammatory bowel disease and psoriasis), Infectious
Diseases and Vaccines (e.g., HIV/AIDS), Neuroscience (e.g., mood disorders and
schizophrenia), Oncology (e.g., prostate cancer and hematologic malignancies),
Cardiovascular and Metabolism (e.g., thrombosis and diabetes) and Pulmonary
Hypertension (e.g., Pulmonary Arterial Hypertension), a new therapeutic area,
which was established with the acquisition of Actelion in June 2017. Ana
finally The Medical Devices segment includes a broad range of products used in
the orthopaedic, surgery, cardiovascular, diabetes care and eye health fields.
Johnson & Johnson is the largest healthcare
company by revenue which generated a whopping USD 81.58 billion in total sales
in 2018, and pharmaceuticals franchise were responsible for more than 50% of
the conglomerate's top line. In 2018, annual consumer care franchise rose just
1.8% and the medical device segment generated a marginal 1.5% gain. Quite
evidently, Johnson & Johnson's pharmaceutical run the show and pushed total
revenue to 7% higher last year.
The Company expected to generate sales of $80.4
billion to $81.2 billion reflecting expected operational growth in the range of
0.0% to 1.0% and expected adjusted operational growth in the range of 2.0% to
3.0%.
Spanning over 31 pages and 14 exhibits, “Johnson
& Johnson - Company Snapshot & SWOT Analysis” report provides value
chain analysis, financial performance, business strategy and SWOT analysis for
company.
Scope of the Johnson & Johnson - Company
Snapshot & SWOT Analysis Report
- This report provides detailed information about
Johnson & Johnson including value chain analysis, financial performance,
business strategy and SWOT analysis.
- The report identifies the growth drivers and
inhibitors for global pharmaceutical market.
- This report provides information about current
and future trends for global pharmaceutical market.
For more details visit: https://www.marketresearchreports.com/navadhi/johnson-johnson-company-snapshot-swot-analysis
Browse more on Pharma andHealthcare Market Research Reports
Read our Interactive Market Research Blog
About NAVADHI Market
Research Pvt Ltd.
NAVADHI is a market research
company that helps global firms differentiate themselves, break market entry
barriers, track their investments, develop business strategies and plan for
future by providing actionable market research intelligence that helps them succeed.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.